People · Operator

Michael DeVille

Named in public records as an officer, director or promoter · active 2015–2016 · Other, Manufacturing

2
Companies
2
Filings
$13.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Lifefactory, Inc.OtherSeries A$9.5M$81.8M2015
Tcho Ventures IncManufacturingSeries A$4.2M$42.1M2016
Operator network

Michael DeVille at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Peter Henig · 3 companies · 1 sharedPeter HenigAndrea Freedman · 1 companies · 1 sharedAndrea FreedmanCarter Weiss · 1 companies · 1 sharedCarter WeissDaren Joy · 1 companies · 1 sharedDaren JoyPerry D. Klebahn · 1 companies · 1 sharedPerry D. KlebahnPeter D. Henig · 1 companies · 1 sharedPeter D. HenigRoy D. Mabrey · 1 companies · 1 sharedRoy D. MabreyRoy Mabrey · 1 companies · 1 sharedRoy MabreyJames Harris · 10 companies · 1 sharedJames HarrisMarcel Bens · 8 companies · 1 sharedMarcel BensBenjamin Fineberg · 2 companies · 1 sharedBenjamin FinebergHans Heer · 2 companies · 1 sharedHans HeerAndrew Dumke · 1 companies · 1 sharedAndrew DumkeJohn Barline · 1 companies · 1 sharedJohn BarlineLifefactory, Inc. · $9.5M raisedLifefactory, Inc.Tcho Ventures Inc · $4.2M raisedTcho Ventures IncMichael DeVilleMD
Michael DeVille Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Michael DeVille on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
James Harris110
Marcel Bens18
Peter Henig13
Hans Heer12
Benjamin Fineberg12
Andrew Dumke11
John Barline11
Perry D. Klebahn11
Roy D. Mabrey11
Peter D. Henig11
Carter Weiss11
Andrea Freedman11
Daren Joy11
Roy Mabrey11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.